Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Piperno

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
The Journal of Applied Laboratory Medicine|September 3, 2025
In Reply to Reference Intervals for Ceruloplasmin Should Account for Age, Sex, Method, and Local PopulationSara Pelucchi, Giulia Risca, Alberto Piperno, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2011
Iron metabolism in thalassemia and sickle cell diseaseRaffaella Mariani, Paola Trombini, Matteo Pozzi, et al.
World Journal of Gastroenterology|February 6, 2009
Hepcidin modulation in human diseases: from research to clinicAlberto Piperno, Raffaella Mariani, Paola Trombini, et al.
European Journal of Case Reports in Internal Medicine|May 6, 2022
Rhabdomyolysis after Intravenous Ferric Gluconate: A Case ReportMara Botti, Alberto Piperno, Annalia Cianflone, et al.
Blood Cells, Molecules & Diseases|January 19, 2016
Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia?Sara Pelucchi, Irene Pelloni, Cristina Arosio, et al.
British Journal of Haematology|November 28, 2008
Reduced expression of hepcidin in patients with myelodysplastic syndrome and myelofibrosis: the causes might be more heterogeneous than in thalassaemiaRaffaella Mariani, Sara Pelucchi, Matteo Pozzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 4, 2020
Ferroportin disease: A novel SLC40A1 mutationGiulia Ravasi, Sara Pelucchi, Andrea Russo, et al.
Blood|April 18, 2009
Homozygous deletion of HFE: the Sardinian hemochromatosis?Sara Pelucchi, Raffaella Mariani, Francesca Bertola, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 16, 2017
Myelodysplastic Syndromes and Iron Chelation TherapyEmanuele Angelucci, Silvana Anna Maria Urru, Federica Pilo, et al.
Haematologica|June 1, 2005
Erythrocytapheresis plus erythropoietin: an alternative therapy for selected patients with hemochromatosis and severe organ damageRaffaella Mariani, Sara Pelucchi, Paolo Perseghin, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
The Journal of Applied Laboratory Medicine|September 3, 2025
In Reply to Reference Intervals for Ceruloplasmin Should Account for Age, Sex, Method, and Local PopulationSara Pelucchi, Giulia Risca, Alberto Piperno, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2011
Iron metabolism in thalassemia and sickle cell diseaseRaffaella Mariani, Paola Trombini, Matteo Pozzi, et al.
World Journal of Gastroenterology|February 6, 2009
Hepcidin modulation in human diseases: from research to clinicAlberto Piperno, Raffaella Mariani, Paola Trombini, et al.
European Journal of Case Reports in Internal Medicine|May 6, 2022
Rhabdomyolysis after Intravenous Ferric Gluconate: A Case ReportMara Botti, Alberto Piperno, Annalia Cianflone, et al.
Blood Cells, Molecules & Diseases|January 19, 2016
Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia?Sara Pelucchi, Irene Pelloni, Cristina Arosio, et al.
British Journal of Haematology|November 28, 2008
Reduced expression of hepcidin in patients with myelodysplastic syndrome and myelofibrosis: the causes might be more heterogeneous than in thalassaemiaRaffaella Mariani, Sara Pelucchi, Matteo Pozzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 4, 2020
Ferroportin disease: A novel SLC40A1 mutationGiulia Ravasi, Sara Pelucchi, Andrea Russo, et al.
Blood|April 18, 2009
Homozygous deletion of HFE: the Sardinian hemochromatosis?Sara Pelucchi, Raffaella Mariani, Francesca Bertola, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 16, 2017
Myelodysplastic Syndromes and Iron Chelation TherapyEmanuele Angelucci, Silvana Anna Maria Urru, Federica Pilo, et al.
Haematologica|June 1, 2005
Erythrocytapheresis plus erythropoietin: an alternative therapy for selected patients with hemochromatosis and severe organ damageRaffaella Mariani, Sara Pelucchi, Paolo Perseghin, et al.
Pageof 10